Effects of Plasmid DNA Injection on Cyclophosphamide-Accelerated Diabetes in NOD Mice

Filippova, Maria; Liu, Jingxue; Escher, Alan
March 2001
DNA & Cell Biology;Mar2001, Vol. 20 Issue 3, p175
Academic Journal
Type 1 diabetes results in most cases from the destruction of insulin-secreting beta cells by the immune system. Several immunization methods based on administration of autoantigenic polypeptides such as insulin and glutamic acid decarboxylase (GAD) have been used to prevent autoimmune diabetes in the non-obese diabetic (NOD) mouse. In the work presented here, a gene-based approach was taken for a similar purpose. A plasmid carrying different cDNAs was used to investigate the effects of injecting naked DNA on cyclophosphamide-accelerated diabetes in female NOD mice. Four-week-old animals received intramuscular injections of plasmid DNA encoding either intracellular GAD, a secreted form of GAD, or a secreted form of a soft coral luciferase. Monitoring of glycosuria and hyperglycemia indicated that injection of plasmid DNA encoding secreted GAD and secreted luciferase could prevent and delay diabetes, respectively. In contrast, injection of DNA encoding intracellular GAD did not suppress the disease significantly. Analysis of anti-GAD IgG[sub 1] antibody titers in animal sera indicated that diabetes prevention after injection of GAD-encoding DNA was possibly associated with increased Th2-type activity. These results suggest that cellular localization of GAD is a factor to consider in the design of GAD-based genetic vaccines for the prevention of autoimmune diabetes.


Related Articles

  • Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae. McDaniel, L S; Loechel, F; Benedict, C; Greenway, T; Briles, D E; Conry, R M; Curiel, D T // Gene Therapy;Apr97, Vol. 4 Issue 4, p375 

    Pneumococcal surface protein A (PspA) is a protection-eliciting protein of Streptococcus pneumoniae. We observed that immunization of BALB/c mice with a plasmid expressing PspA significantly protected the mice from lethal challenge with S. pneumoniae when compared to control mice that received...

  • Targeting Autoimmune Diabetes With Gene Therapy. Giannoukakis, Nick; Rudert, William A.; Robbins, Paul D.; Trucco, Massimo // Diabetes;Nov99, Vol. 48 Issue 11, p2107 

    Focuses on gene-therapy approaches in the treatment of type 1 diabetes. Autoimmune nature of type 1 diabetes; Pancreatic islets as gene transfer vehicles; Allogeneic transplantation; Xenotransplantation.

  • Reversal of Diabetes by Inducing Islet Neogenesis Using Helper Dependent Adenovirus Mediated Gene Therapy  // Molecular Therapy;May2004 Supplement 1, Vol. 9, p16 

    An abstract of the article "Reversal of Diabetes by Inducing Islet Neogenesis Using Helper Dependent Adenovirus Mediated Gene Therapy," by Vijay Yechoor, Hideto Kojima, Mineko Fujimiya, Bonne Thompson, Benny Chang, Laura Nelly, Philip Ng, and Lawrence Chan is presented.

  • Efficient Gene Expression in Skin Wound Sites Following Local Plasmid Injection. Meuli, Martin; Liu, Yong; Liggitt, Denny; Kashani-Sabet, Mohammed; Knauer, Sharon; Meuli-Simmen, Claudia; Harrison, Michael R.; Adzick, N. Scott; Heath, Timothy D.; Debs, Robert J. // Journal of Investigative Dermatology;Jan2001, Vol. 116 Issue 1, p131 

    SummaryTransfection of the skin by local gene delivery, as well as widespread transfection of systemic tissues following intravenous injection of cationic liposome/DNA complexes have been reported. Here, we show that surgically wounded mouse skin can be transfected either by local injection of...

  • The φC31 Integrase System for Gene Therapy. Calos, Michele P. // Current Gene Therapy;Dec2006, Vol. 6 Issue 6, p633 

    The φC31 integrase system represents a novel technology that opens up new possibilities for gene therapy. The φC31 integrase can integrate introduced plasmid DNA into preferred locations in unmodified mammalian genomes, resulting in robust, long-term expression of the integrated...

  • Visualization of the transgene distribution according to the administration route allows prediction of the transfection efficacy and validation of the results obtained. Delepine, P.; Montier, T.; Guillaume, C.; Vaysse, L.; Le Pape, A.; Ferec, C. // Gene Therapy;6/1/2002, Vol. 9 Issue 11, p736 

    Gene transfer to the lung can be achieved via a systemic, that targets the endothelium, or local, that targets the epithelium, delivery route. In the present study, we followed the distribution of a plasmid after transfection using some of our phosphonolipids, which have previously shown their...

  • Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism. Adler, Amos; Shklyar, Maya; Schwaber, Mitchell J.; Navon-Venezia, Shiri; Dhaher, Yacoub; Edgar, Rotem; Solter, Ester; Benenson, Shmuel; Masarwa, Samira; Carmeli, Yehuda // Journal of Antimicrobial Chemotherapy (JAC);Dec2011, Vol. 66 Issue 12, p2763 

    Objectives The carbapenemase OXA-48 has been reported from different Mediterranean countries. It is mostly encoded on a single plasmid in various Enterobacteriaceae species. We characterized the epidemiological and molecular features of OXA-48-producing Enterobacteriaceae (OPE) in Israel....

  • EYEVENSYS CLOSES $8.5M IN SERIES A FINANCING.  // Worldwide Biotech;Dec2015, Vol. 27 Issue 12, p4 

    The article reports on the investment of drugmaker Eyevensys SA for the development of innovative DNA plasmid-associated combination product EYS606. Topics discussed include the development of EYS606 for Non-Infectious Posterior Uveitis (NIU) treatment, the support received by the development,...

  • pMdT1, a small ColE1-like plasmid mobilizing a new variant of the aac(6′)-Ib-cr gene in Salmonella enterica serovar Typhimurium. de Toro, María; Rodríguez, Irene; Rojo-Bezares, Beatriz; Helmuth, Reiner; Torres, Carmen; Guerra, Beatriz; Sáenz, Yolanda // Journal of Antimicrobial Chemotherapy (JAC);Jun2013, Vol. 68 Issue 6, p1277 

    Objectives To characterize a 5.9 kb aac(6′)-Ib-cr-harbouring plasmid that was detected in a clinical Salmonella Typhimurium DT104B strain. Methods Extraction and purification of plasmid DNA and electrotransformation assays were carried out in order to obtain kanamycin-resistant...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics